加载中
Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advanced software complete with connectivity features. Founded in 2003, the company initially operated under the name Home Dialysis Plus, Ltd. before rebranding to Outset Medical, Inc. in January 2015. Its corporate headquarters are located in San Jose, California.
前收盘价
US$4.05
−US$0.04 · -0.98%
盘中时间采用ET。市场数据可能有所延迟。
Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advanced software complete with connectivity features. Founded in 2003, the company initially operated under the name Home Dialysis Plus, Ltd. before rebranding to Outset Medical, Inc. in January 2015. Its corporate headquarters are located in San Jose, California.
日内区间
当前US$4.05
52周区间
当前US$4.05
盘中时间采用ET。市场数据可能有所延迟。
Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advanced software complete with connectivity features. Founded in 2003, the company initially operated under the name Home Dialysis Plus, Ltd. before rebranding to Outset Medical, Inc. in January 2015. Its corporate headquarters are located in San Jose, California.
日内区间
当前US$4.05
52周区间
当前US$4.05
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 1.19亿 USD | 1.14亿 USD | 1.3亿 USD | 1.15亿 USD | 1.03亿 USD |
| 销货成本 | 7272.2万 USD | 7512.5万 USD | 1.01亿 USD | 9754.2万 USD | 9499.4万 USD |
| 毛利 | 4675.4万 USD | 3856.4万 USD | 2900万 USD | 1783.3万 USD | 760.8万 USD |
| 研究与开发 | 2123.5万 USD | 3839.7万 USD | 5730.7万 USD | 4885.5万 USD | 3674.1万 USD |
| 销售、一般及管理费用 | 9222.5万 USD | 1.14亿 USD | 1.41亿 USD | 1.3亿 USD | 1.01亿 USD |
| 营业费用 | 1.13亿 USD | 1.52亿 USD | 1.99亿 USD | 1.79亿 USD | 1.38亿 USD |
| 利息收入 | 740.8万 USD | 976.1万 USD | 1017.1万 USD | 329.1万 USD | 49.8万 USD |
| 利息支出 | 1395.2万 USD | 2387.1万 USD | 1267.5万 USD | 356.6万 USD | 171.5万 USD |
| 折旧和摊销 | 434.1万 USD | 572.8万 USD | 581万 USD | 516.9万 USD | 516.2万 USD |
| 营业利润 | −6671.4万 USD | −1.13亿 USD | −1.7亿 USD | −1.61亿 USD | −1.31亿 USD |
| 净利润 | −8165.3万 USD | −1.28亿 USD | −1.73亿 USD | −1.63亿 USD | −1.32亿 USD |
公司数据更新于 2026年10月11日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$14.00
上涨空间 245.68%| 行动 | 生效日期 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股票拆分 | 2025年3月20日 | 1:15 | — | — |
已生效 2025年3月20日
1:15
报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI211.18万0.00%2.3万亿 USD0.03%US$381.94+0.63%
Vanguard Extended Market ETFVXF78.9万0.00%954亿 USD0.05%US$235+0.80%
iShares Micro-Cap ETFIWC22.46万0.02%13.17亿 USD0.60%US$183+0.11%
Dimensional - US Small Cap ETFDFAS20.48万0.00%338.69亿 USD0.31%US$78.35+0.32%
Fidelity Disruptive Medicine ETFFMED13.91万0.28%5231万 USD0.50%US$31.4003+2.73%
Avantis U.S. Small Cap Equity ETFAVSC10.93万—30.82亿 USD0.25%US$69.98+0.03%
EA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSM10万0.09%1.17亿 USD0.73%US$15.9402+0.25%
Dimensional - US Core Equity 2 ETFDFAC9.95万0.00%885.96亿 USD0.21%US$45.33+0.49%Vanguard Morningstar Total Stock Market ETFVTIVanguard Extended Market ETFVXFiShares Micro-Cap ETFIWCDimensional - US Small Cap ETFDFASFidelity Disruptive Medicine ETFFMEDAvantis U.S. Small Cap Equity ETFAVSCEA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSMDimensional - US Core Equity 2 ETFDFACAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
